SoftOx Solutions AS ("SoftOx" or the "Company"), a clinical-stage
biopharmaceutical company, with a separate disinfection branch in Norway, has
received the Swedish Chemicals Agency's final product assessment draft for the
SoftOx disinfection family. SoftOx has reviewed the report and notified the
Agency that the company fully supports it. The next step is a final decision on
the application for SoftOx's hand- and surface disinfectants.

With an approval from the Swedish Chemicals Agency, SoftOx can apply for mutual
recognition in sequence in any EU market, including Norway.  Furthermore, in
parallel and in line with the company's strategy, SoftOx will initiate talks
with several potential distributors and disinfection players to bring the
company's competitive disinfection technology to market both in Europe and
internationally.  

For further information, please contact:
Geir Almås, CEO of SoftOx Solutions AS
Mail: ir@soft-ox.com
Phone: Front Desk: (+47) 948-59-599

About SoftOx Solutions AS
SoftOx Solutions AS (SoftOx, listed on Euronext Growth Oslo) is a Norwegian
biopharmaceutical and MedTech company based in Oslo, with the goal of reducing
the spread of infection and emergence of antimicrobial resistance. For more
information on SoftOx, visit www.soft-ox.com

Click here for more information

© Oslo Bors ASA, source Oslo Stock Exchange